CRIS Current Research Information System

MONTANARO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.825
AS - Asia 4.116
EU - Europa 3.502
Continente sconosciuto - Info sul continente non disponibili 223
AF - Africa 211
SA - Sud America 200
OC - Oceania 11
Totale 13.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.756
SG - Singapore 1.107
VN - Vietnam 1.077
CN - Cina 1.016
IT - Italia 974
GB - Regno Unito 768
DE - Germania 423
SE - Svezia 295
HK - Hong Kong 276
UA - Ucraina 261
FR - Francia 209
IN - India 177
RU - Federazione Russa 171
BR - Brasile 146
IE - Irlanda 106
JP - Giappone 105
KR - Corea 94
BD - Bangladesh 86
NL - Olanda 67
CI - Costa d'Avorio 64
ZA - Sudafrica 62
FI - Finlandia 48
CA - Canada 37
EE - Estonia 37
BE - Belgio 33
JO - Giordania 31
TG - Togo 31
PH - Filippine 28
AR - Argentina 25
GR - Grecia 20
AT - Austria 18
MX - Messico 18
SC - Seychelles 18
TR - Turchia 16
ID - Indonesia 15
NG - Nigeria 15
IR - Iran 14
CH - Svizzera 13
PK - Pakistan 12
AU - Australia 11
IQ - Iraq 11
PL - Polonia 10
TH - Thailandia 10
TW - Taiwan 10
HR - Croazia 9
CO - Colombia 8
BG - Bulgaria 7
EC - Ecuador 7
UZ - Uzbekistan 7
LT - Lituania 6
AL - Albania 5
CL - Cile 5
ES - Italia 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
CR - Costa Rica 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
TN - Tunisia 4
CZ - Repubblica Ceca 3
LB - Libano 3
MA - Marocco 3
VE - Venezuela 3
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
KZ - Kazakistan 2
NP - Nepal 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BT - Bhutan 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.866
Salva come PNG Salva come JPEG
Città #
Singapore 749
Southend 656
Ashburn 385
Santa Clara 368
Chandler 339
San Jose 330
Fairfield 293
Hong Kong 267
Dong Ket 239
Ho Chi Minh City 208
Hefei 207
Jacksonville 199
Princeton 183
Wilmington 171
Hanoi 160
Council Bluffs 146
Woodbridge 137
Houston 136
Ann Arbor 135
Seattle 132
Dallas 109
Dublin 106
Beijing 105
Los Angeles 96
Tokyo 95
Cambridge 93
Boardman 89
Lauterbourg 86
Seoul 84
Padova 69
Westminster 68
Abidjan 64
Bologna 63
Nanjing 62
Milan 59
Rome 59
New York 48
Buffalo 45
Mülheim 45
Helsinki 42
Berlin 39
Bremen 39
Medford 37
Saint Petersburg 35
Shenyang 34
Amman 31
Lomé 31
Haiphong 30
Brussels 29
Da Nang 28
San Diego 26
San Venanzo 26
Hebei 25
Florence 24
Shanghai 24
Nanchang 23
Jinan 22
Munich 22
Frankfurt am Main 21
Redondo Beach 20
Atlanta 19
Changsha 19
Guangzhou 19
Jiaxing 19
The Dalles 19
Palermo 18
Phoenix 18
Mahé 17
São Paulo 16
London 15
Zhengzhou 15
Bengaluru 14
Dearborn 14
Olalla 14
Orem 14
Abeokuta 13
Shenzhen 13
Tianjin 13
Wuhan 13
Biên Hòa 12
Pescara 11
San Francisco 11
Verona 11
Brooklyn 10
Chicago 10
Fuzhou 10
Montreal 10
Ningbo 10
Norwalk 10
Nuremberg 10
Bến Tre 9
Chennai 9
Denver 9
Falkenstein 9
Falls Church 9
Hangzhou 9
Kunming 9
Xi'an 9
Bühl 8
Ferrero 8
Totale 7.998
Salva come PNG Salva come JPEG
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 624
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 315
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions 288
Le basi della farmacologia 272
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 230
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 217
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 216
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 216
Ticlopidine Safety Profile: A Case/Non-Case Study on the Basis of the Spontaneous ADRs Reporting in Italy 212
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature 204
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). 196
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database 194
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 192
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 191
An update on the first decade of the European centralized procedure: how many innovative drugs? 190
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 190
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 187
Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database 183
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System 180
Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug’s safety profile. 178
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 175
Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 171
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database 170
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database 168
Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data 167
Hepatic adverse drug reactions: a case/non-case study in Italy 159
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 158
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 158
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations 157
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 156
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 156
Antibiotic use in Italian hospitals 2002-2004. 155
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy 155
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations 154
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 153
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 153
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 152
Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy 149
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 148
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine 147
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 145
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 145
Therapeutic innovation of the drugs approved by the EMEA-centralised procedure 144
Initial treatment of hypertension and adherence to therapy in general practice in Italy 144
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. 143
La rimborsabilità di memantina - il trilemma di Münchausen 143
Un commento alla lettera sulla definizione di farmaco innovativo 143
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 142
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 141
Progetto europeo di confronto dell'uso dei farmaci 137
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 136
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 136
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 133
Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System 132
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. 132
Farmaci EMEA ed innovazione terapeutica 129
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 125
Pattern of Triptan Use in a Sample of the Italian General Population 125
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 125
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice 125
The Influence of Notoriety Bias on ADR Spontaneous Reporting Rate. 124
Natalizumab: a country-based surveillance program 124
Three years of experience: the Italian registry and safety data update 122
Prevenire gli errori in terapia. Strategie per i farmacisti 120
Removal of the EMA orphan designation upon request of the sponsor: cui prodest? 118
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 114
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. 112
Monitoring the use of disease-modifying drugs in multiple sclerosis 112
The Italian Surveillance Program on Natalizumab 108
Hepatic adverse drug reactions: analysis of an italian spontaneous reporting database. 104
Prescrizione di Entacapone nella Regione Emilia-Romagna 104
La medicina basata sulle prove. Dalle fonti di conoscenza alla realtà del singolo paziente. Seconda edizione 100
La medicina basata sulle prove - Istruzioni per l'uso. Prima edizione italiana 99
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 99
The Italian Natalizumab Registry: a 1-year follow-up 97
Pattern of use of NSAIDs in the Italian general population: a questionnaire-based study 96
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data 90
Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database 89
Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis 86
Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use 84
On criteria to evaluate the therapeutic innovation of drugs 81
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data 76
Overview of Orphan Medicines in European Union: An Analysis of Regulatory and Technical-Scientific Aspects 68
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab 67
Use of anti-asthmatic drugs in Italy: Analysis of prescriptions in general practice in the light of guidelines for asthma treatment 52
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview 48
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: An analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions 33
Totale 13.088
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.228 0 49 62 98 120 66 25 93 51 91 355 218
2022/20231.483 159 183 100 203 99 128 28 86 261 45 127 64
2023/2024498 46 69 37 60 42 43 32 42 22 39 50 16
2024/20251.731 69 230 143 86 440 132 87 52 30 55 81 326
2025/20264.292 240 370 408 340 502 202 548 176 717 335 249 205
2026/2027314 155 159 0 0 0 0 0 0 0 0 0 0
Totale 13.088